Teladoc's long-time CEO is leaving

05 Apr 2024

IPOExecutive ChangeAcquisition

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here .) Teladoc Health’s CEO Jason Gorevic is stepping down, the company said on Friday, as the telehealth giant’s stock dropped to an all-time low in eight years. Teladoc’s stock dropped to around $14 per share when markets opened Friday, the lowest price since 2016. Gorevic stepped into his role as CEO in 2009. He oversaw Teladoc’s IPO in 2015 and its acquisition of Livongo in 2020. The company has struggled to make its acquisition of Livongo profitable, reporting a loss of $14 billion on the deal in 2022.

For more details,please visit the original website

The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.

Organizations

Teladoc Health, Inc.

Livongo Health, Inc.

Indications

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.